The Latest Breaking News from DHR

Although Danaher has underperformed the S&P 500 Index over the past year, analysts remain bullish about the stock’s prospects.

Healthcare giant Danaher has significantly underperformed the broader market over the past year, yet analysts remain strongly bullish on the stock’s longer-term prospects.

Healthcare giant Danaher is set to unveil its fourth-quarter earnings later this month and analysts expect a modest single-digit growth in earnings.

Danaher has underperformed the Medical Devices industry, though Wall Street analysts remain strongly optimistic about its future prospects.

Although Danaher has underperformed relative to the broader market over the past year, Wall Street analysts maintain a bullish outlook about the stock’s prospects.

Darjeeling Himalayan Railway (DHR) resumed its Toy train regular services from New Jalpaiguri station to Darjeeling on Sunday after a long gap. Read further on Dynamite News:

With Danaher gearing up to release its third-quarter earnings later this month, analysts expect double-digit earnings decline.

Danaher recently underperformed the healthcare sector, but Wall Street analysts are moderately bullish about the stock’s prospects.

Danaher is expected to release its second-quarter earnings later this month, and analysts project a double-digit bottom-line dip.

The healthcare industry is poised for tremendous growth driven by the aging population and rising incidence of chronic diseases. Hence, quality healthcare stocks, Danaher (DHR), Amgen (AMGN), and DexCom (DXCM), benefiting from an aging population, might be worth looking into. Read more….

Indian medical institutions aim to improve research quality and global rankings, focusing on impactful solutions for citizens' problems.